Ulimorelin Hydrochloride

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameUlimorelin Hydrochloride
Drug Alias Name乌莫瑞林Ulimorelin hydrochlorideulimorelinumulimorelinaulimorelin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsGastrointestinal motility disordersDiabetes MellitusGastroparesis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[16] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOcera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorgineLyric Pharmaceuticals IncTranzyme Inc
Active IndicationsN/A
Inactive IndicationsGastrointestinal motility disordersDiabetes MellitusGastroparesis +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG